Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy

American Journal of Physiology - Endocrinology and Metabolism

Volumn 286, Issue 2 49-2, 2004, Pages

  Koutkia, Polyxeni ^a   Meininger, Gary ^a   Canavan, Bridget ^a   Breu, Jeff ^b   Grinspoon, Steven ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Growth hormone releasing hormone; Human immunodeficiency virus

Indexed keywords

ACIPIMOX; ARGININE; FATTY ACID; GHRELIN; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; INSULIN; SOMATOMEDIN C; SOMATOSTATIN;

ADULT; AGE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; GROWTH HORMONE RELEASE; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LYMPHOCYTE COUNT; MALE; METABOLIC REGULATION; PRIORITY JOURNAL; VIRUS LOAD;

EID: 0942287339     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00335.2003     Document Type: Article

References (36)

1. Alba-Roth J, Muller OA, Schopohl J, and von Werder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metab 67: 1186-1189, 1988.
2. Alvarez CV, Mallo F, Burguera B, Cacicedo L, Dieguez C, and Casanueva FF. Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone-releasing hormone in the rat. Neuroendocrinology 53: 185-189, 1991.
3. Bellone J, Bartolotta E, Cardinale G, Arvat E, Cherubini V, Aimaretti G, Maccario M, Mucci M, Camanni F, and Ghigo E. Low dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children. J Endocrinol Invest 16: 521-525, 1993.
4. Borkan GA, Gerzof SG, Robbins AH, Hults DE, Silbert CK, and Silbert JE. Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 36: 172-177, 1982.
5. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, and Cooper DA. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12: F51-F58, 1998.
6. Clasey JL, Weltman A, Patrie J, Weltman JY, Pezzoli S, Bouchard C, Thorner MO, and Hartman ML. Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. J Clin Endocrinol Metab 86: 3845-3852, 2001.
7. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, and Purnell JQ. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346: 1623-1630, 2002.
8. Flanagan DE, Evans ML, Monsod TP, Rife F, Heptulla RA, Tamborlane WV, and Sherwin RS. The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab 284: E313-E316, 2003.
9. Ghigo E, Arvat E, Valente F, Nicolosi M, Boffano GM, Procopio M, Bellone J, Maccario M, Mazza E, and Camanni F. Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults. Neuroendocrinology 54: 291-294, 1991.
10. Ghigo E, Bellone J, Mazza E, Imperiale E, Procopio M, Valente F, Lala R, De Sanctis C, and Camanni F. Arginine potentiates the GHRH-but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine. Clin Endocrinol (Oxf) 32: 763-767, 1990.
11. Ghigo E, Procopio M, Boffano GM, Arvat E, Valente F, Maccario M, Mazza E, and Camanni F. Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity. Metabolism 41: 560-563, 1992.
12. Hadigan C, Borgonha S, Rabe J, Young V, and Grinspoon S. Increased rates of lipolysis among HIV-infected men receiving highly active antiretroviral therapy. Metabolism 51: 1143-1147, 2002.
13. Hadigan C, Corcoran C, Stanley T, Piecuch S, Klibanski A, and Grinspoon S. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use. J Clin Endocrinol Metab 85: 35-41, 2000.
14. Hadigan C, Meigs JB, Wilson PWF, D'Agostino RB, Davis B, Basgoz N, Sax PE, and Grinspoon S. Prediction of coronary heart disease in HIV-infected patients with fat redistribution. Clin Inf Dis. 36: 909-916, 2003.
15. Hadigan C, Rabe J, Meininger G, Aliabadi N, Breu J, and Grinspoon S. Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution. Am J Clin Nutr 77: 490-494, 2003.
16. Imaki T, Shibasaki T, Masuda A, Hotta M, Yamauchi N, Demura H, Shizume K, Wakabayashi I, and Ling N. The effect of glucose and free fatty acids on growth hormone (GH)-releasing factor-mediated GH secretion in rats. Endocrinology 118: 2390-2394, 1986.
17. Jaffe CA, Friberg RD, and Barkan AL. Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses. J Clin Invest 92: 695-701, 1993.
18. Johansen K, Rasmussen MH, Kjems LL, and Astrup A. An unusual type of familial lipodystrophy. J Clin Endocrinol Metab 80: 3442-3446, 1995.
19. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660, 1999.
20. Maccario M, Procopio M, Grottoli S, Oleandri SE, Boffano GM, Taliano M, Camanni F, and Ghigo E. Effects of acipimox, an antilipolytic drug, on the growth hormone response to GH-releasing hormone alone or combined with arginine in obesity. Metabolism 45: 342-346, 1996.
21. Maccario M, Procopio M, Loche S, Cappa M, Martina V, Camanni F, and Ghigo E. Interaction of free fatty acids and arginine on growth hormone secretion in man. Metabolism 43: 223-226, 1994.
22. Magiakou MA, Mastorakos G, Gomez MT, Rose SR, and Chrousos GP. Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure. J Clin Endocrinol Metab 78: 131-137, 1994.
23. Miller KK, Daly PA, Sentochnik D, Doweiko J, Samore M, Basgoz NO, and Grinspoon SK. Pseudo-Cushing's syndrome in human immunodeficiency virus-infected patients. Clin Infect Dis 27: 68-72, 1998.
24. Muller AF, Lamberts SW, Janssen JA, Hofland LJ, Koetsveld PV, Bidlingmaier M, Strasburger CJ, Ghigo E, and Van der Lely AJ. Ghrelin drives GH secretion during fasting in man. Eur J Endocrinol 146: 203-207, 2002.
25. Pontiroli AE, Lanzi R, Monti LD, and Pozza G. Effect of acipimox, a lipid lowering drug, on growth hormone (GH) response to GH-releasing hormone in normal subjects. J Endocrinol Invest 13: 539-542, 1990.
26. Rietschel P, Hadigan C, Corcoran C, Stanley T, Neubauer G, Gertner J, and Grinspoon S. Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy. J Clin Endocrinol Metab 86: 504-510, 2001.
27. Sekhar RV, Jahoor F, White AC, Pownall HJ, Visnegarwala F, Rodriguez-Barradas MC, Sharma M, Reeds PJ, and Balasubramanyam A. Metabolic basis of HIV-lipodystrophy syndrome. Am J Physiol Endocrinol Metab 283: E332-E337, 2002.
28. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, and Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87: 240-244, 2002.
29. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, and Nakao K. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85: 4908-4911, 2000.
30. Thorner MO, Chapman IM, Gaylinn BD, Pezzoli SS, and Hartman ML. Growth hormone-releasing hormone and growth hormone-releasing peptide as therapeutic agents to enhance growth hormone secretion in disease and aging. Recent Prog Horm Res 52: 215-244, 1997.
31. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, and Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 50: 707-709, 2001.
32. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, and Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 72: 51-59, 1991.
33. Veldhuis JD and Johnson ML. Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol Endocrinol Metab 250: E486-E493, 1986.
34. Veldhuis JD and Johnson ML. Analytical methods for evaluating episodic secretory activity within neuroendocrine axes. Neurosci Biobehav Rev 18: 605-612, 1994.
35. Veldhuis JD, Johnson ML, and Seneta E. Analysis of the copulsatility of anterior pituitary hormones. J Clin Endocrinol Metab 73: 569-576, 1991.
36. Veldhuis JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA, Abbott R, Mulligan T, Johnson ML, and Pincus S. Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 80: 3209-3222, 1995.